ITRM vs WFC · rev $390.0K vs P/E 15, $272.05B cap
Iterum Therapeutics PLC (ITRM) versus Wells Fargo & Company (WFC) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Wells Fargo & Company (WFC) is a banks - diversified company listed on US. It is led by Charlie Scharf.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
WFC does not have a complete income-statement cache yet.
ITRM currently screens at market cap $38.6M. WFC currently screens at market cap $272.05B and trailing P/E 15.0.
Not investment advice. Open the ITRM and WFC stock pages for the full models.
Not investment advice.